News & Updates

Use of an oral herbal supplement appears to be more favourable than oestrogen plus progestogen therapy in terms of reducing global, physical, and psychosocial menopausal symptoms in the short term, according to a phase II study.

Receipt of mRNA COVID-19 vaccination during pregnancy does not appear to increase the incidence of adverse newborn and early infant outcomes and may even be protective, according to a study.

Children conceived with assisted reproductive technology (ART) appear to be at slightly increased risk for developing genitourinary abnormalities, according to a study.

Treatment with faster-acting insulin aspart in pregnant women with diabetes appears to have no adverse effect on foetal growth and even leads to fewer episodes of hypoglycaemia, according to the Copenfast trial.

Use of foetal echocardiograms results in an accurate diagnosis of congenital heart diseases (CHDs), with good concordance between pre- and postnatal diagnoses, according to a Singapore study.

Women with a history of pelvic inflammatory disease appear to be at increased risk of epithelial ovarian cancer (EOC), according to a study.

New drug applications approved by US FDA as of 15-30 September 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.